Indaptus Therapeutics, Inc.
INDP
$2.51
$0.4823.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.93% | -96.38% | 3.06% | -30.22% | -19.06% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 164.55% | 158.40% | 16.23% | 23.71% | -68.90% |
| Change in Net Operating Assets | -575.79% | 859.21% | -197.14% | -67.89% | 16.53% |
| Cash from Operations | -38.89% | 6.04% | -2.16% | -62.15% | -28.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.92% | -22.02% | 1,355.95% | 936.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 61.19% | 74.51% | -233.33% | -1,556.50% |
| Cash from Financing | -- | 225.92% | -13.76% | 16,395.80% | 897.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -269.78% | 268.27% | -520.91% | 192.90% | 47.64% |